drugset / Trial / NCT05702827

Use of a Dual-agent Local Analgesic (Bupivacaine-meloxicam) for Abdominal Incisions in Patients Undergoing Retropubic Mid-urethral Sling Surgery

NCT05702827

Phase 3 Completed 148 enrolled TriHealth Inc.
RandomizedParallel-groupSingle-blindTreatment

Summary

This study will compare the use of a dual-agent local analgesic (bupivacaine-meloxicam) for abdominal incisions in patients undergoing retropubic mid-urethral sling surgery to see if narcotic usage and pain are impacted.

Timeline

Start
2023-01-23
Primary completion
2024-03-22
Completion
2024-04-18

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified Other
Subject Meloxicam Small molecule Other